Redhill Biopharma Ltd (NASDAQ:RDHL)

15.41
Delayed Data
As of 3:59pm ET
 -0.89 / -5.46%
Today’s Change
6.89
Today|||52-Week Range
22.22
+15.60%
Year-to-Date
No recent news for Redhill Biopharma Ltd.

Today’s Trading

Previous close16.30
Today’s open16.41
Day’s range15.25 - 16.41
Volume120,286
Average volume (3 months)108,417
Market cap$202.5M
Dividend yield--
Data as of 3:59pm ET, 07/28/2015

Growth & Valuation

Earnings growth (last year)+30.60%
Earnings growth (this year)-12.88%
Earnings growth (next 5 years)--
Revenue growth (last year)+57,366.26%
P/E ratio--
Price/Sales16.81
Price/Book5.68

Competitors

 Today’s
change
Today’s
% change
ALIMAlimera Sciences Inc+0.33+7.24%
MDGNMedgenics Inc+0.19+2.36%
STMLStemline Therapeutic...+0.26+2.28%
CYNACynapsus Therapeutic...-0.01-0.06%
Data as of 4:02pm ET, 07/28/2015

Financials

Next reporting dateJuly 29, 2015
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$6.9M
Annual profit (last year)-$10.6M
Net profit margin-152.71%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Dror Ben-Asher
Director, Deputy CEO-Finance &
Operations
Ori Shilo
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers